OR

Browse By

Intramuscular allosteric agonism of purinergic P2X7 receptor as a pharmacological approach to enhance skeletal muscle regeneration in Amyotrophic Lateral Sclerosis (FightMND administered by IRFMN) (2022–2025)

Grant type:
IRCCS - Istituto di Ricerche Farmacologiche Mario Negri
Researchers:

  • Associate Professor Shyuan Ngo

    Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology

  • Associate Professor Frederik Steyn

    Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
    Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
Funded by:
IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (externally led for Cure for MND Foundation)